A novel risk classifier to predict the in-hospital death risk of nosocomial infections in elderly cancer patients

Background Elderly cancer patients are more predisposed to developing nosocomial infections during anti-neoplastic treatment, and are associated with a bleaker prognosis. This study aimed to develop a novel risk classifier to predict the in-hospital death risk of nosocomial infections in this population. Methods Retrospective clinical data were collected from a National Cancer Regional Center in Northwest China. The Least Absolute Shrinkage and Selection Operator (LASSO) algorithm was utilized to filter the optimal variables for model development and avoid model overfitting. Logistic regression analysis was performed to identify the independent predictors of the in-hospital death risk. A nomogram was then developed to predict the in-hospital death risk of each participant. The performance of the nomogram was evaluated using receiver operating characteristics (ROC) curve, calibration curve, and decision curve analysis (DCA). Results A total of 569 elderly cancer patients were included in this study, and the estimated in-hospital mortality rate was 13.9%. The results of multivariate logistic regression analysis showed that ECOG-PS (odds ratio [OR]: 4.41, 95% confidence interval [CI]: 1.95-9.99), surgery type (OR: 0.18, 95%CI: 0.04-0.85), septic shock (OR: 5.92, 95%CI: 2.43-14.44), length of antibiotics treatment (OR: 0.21, 95%CI: 0.09-0.50), and prognostic nutritional index (PNI) (OR: 0.14, 95%CI: 0.06-0.33) were independent predictors of the in-hospital death risk of nosocomial infections in elderly cancer patients. A nomogram was then constructed to achieve personalized in-hospital death risk prediction. ROC curves yield excellent discrimination ability in the training (area under the curve [AUC]=0.882) and validation (AUC=0.825) cohorts. Additionally, the nomogram showed good calibration ability and net clinical benefit in both cohorts. Conclusion Nosocomial infections are a common and potentially fatal complication in elderly cancer patients. Clinical characteristics and infection types can vary among different age groups. The risk classifier developed in this study could accurately predict the in-hospital death risk for these patients, providing an important tool for personalized risk assessment and clinical decision-making.

[1]  A. Jemal,et al.  Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[2]  Wan-yang Li,et al.  Effect of malnutrition and nutritional support to reduce infections in elderly hospitalized patients with cancer: A multicenter survey in China. , 2022, Nutrition.

[3]  C. Sprung,et al.  Outcomes and predictors of 28-day mortality in patients with solid tumors and septic shock defined by Sepsis-3 criteria. , 2022, Chest.

[4]  Yanping Xiao,et al.  Association among prognostic nutritional index, post-operative infection and prognosis of stage II/III gastric cancer patients following radical gastrectomy , 2022, European Journal of Clinical Nutrition.

[5]  Xuan Liang,et al.  Establishment and validation of a nomogram to predict the in-hospital death risk of nosocomial infections in cancer patients , 2022, Antimicrobial Resistance & Infection Control.

[6]  C. Sprung,et al.  Outcomes and Predictors of 28-Day Mortality in Patients With Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  N. Rezaei,et al.  Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis , 2021, Frontiers in Immunology.

[8]  M. Abdullah,et al.  A 12-year study evaluating the outcomes and predictors of mortality in critically ill cancer patients admitted with septic shock , 2021, BMC cancer.

[9]  J. Carratalá,et al.  Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance , 2021, Frontiers in Medicine.

[10]  T. Ozgurtas,et al.  A new COVID-19 prediction scoring model for in-hospital mortality: experiences from Turkey, single center retrospective cohort analysis. , 2020, European review for medical and pharmacological sciences.

[11]  Rui Zhao,et al.  The prognostic value of pretreatment prognostic nutritional index in patients with small cell lung cancer and it’s influencing factors: a meta-analysis of observational studies , 2020, Journal of thoracic disease.

[12]  Xuan Liang,et al.  Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China , 2020, BMC Infectious Diseases.

[13]  Dongying Chen,et al.  Epidemiology and Mortality-Associated Factors of Invasive Fungal Disease in Elderly Patients: A 20-Year Retrospective Study from Southern China , 2020, Infection and drug resistance.

[14]  Rui Zhang,et al.  Clinical outcomes and prognostic factors in bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a meta-analysis , 2020, Annals of clinical microbiology and antimicrobials.

[15]  T. Buchman,et al.  Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012–2018* , 2020, Critical care medicine.

[16]  T. Buchman,et al.  Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018* , 2020, Critical care medicine.

[17]  John A. Bohlin,et al.  Statistical predictions with glmnet , 2019, Clinical Epigenetics.

[18]  J. Carratalá,et al.  Current etiology, clinical features and outcomes of bacteremia in older patients with solid tumors. , 2019, Journal of geriatric oncology.

[19]  Chang-ming Huang,et al.  Does Intra-Abdominal Infection after Curative Gastrectomy Affect Patients' Long-Term Prognosis? A Multi-Center Study Based on a Large Sample Size. , 2019, Surgical infections.

[20]  Tingting Zhang,et al.  Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[21]  C. Flowers,et al.  Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  P. Hsueh,et al.  Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013. , 2017, International journal of antimicrobial agents.

[23]  A. Oliver,et al.  Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-&bgr;-lactamase-producing Enterobacteriaceae , 2017, The Journal of antimicrobial chemotherapy.

[24]  Kathleen F. Kerr,et al.  Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Seo,et al.  Prevention and treatment of cancer-related infections, version 2.2016 , 2016 .

[26]  K. Czene,et al.  Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis. , 2016, The Journal of infection.

[27]  H. Yoon,et al.  Febrile Urinary Tract Infection after Radical Cystectomy and Ileal Neobladder in Patients with Bladder Cancer , 2016, Journal of Korean medical science.

[28]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[29]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[30]  J. Aguado,et al.  Bloodstream infections in patients with solid tumors , 2016, Virulence.

[31]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[32]  Debashis Ghosh,et al.  Penalized regression procedures for variable selection in the potential outcomes framework , 2015, Statistics in medicine.

[33]  F. Kokturk,et al.  Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia. , 2013, Journal of geriatric oncology.

[34]  W. Ko,et al.  Antimicrobial susceptibility of bacteremic isolates from cancer patients with or without neutropenia at a medical center in southern Taiwan. , 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[35]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[36]  K. Sepkowitz,et al.  Nosocomial infections in patients with cancer. , 2009, The Lancet. Oncology.

[37]  G. Maschmeyer,et al.  The epidemiology and treatment of infections in cancer patients. , 2008, International journal of antimicrobial agents.

[38]  Stanley Lemeshow,et al.  Assessing the Fit of the Model , 2005 .

[39]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[40]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.